The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares.

Summary

# Editorial Summary Endometrosis represents a chronic degenerative condition affecting the equine endometrium, yet its effects on myometrial function—critical for embryo transport and fertility—remain poorly characterised. Researchers examined how lysophosphatidic acid (LPA), a bioactive lipid mediator, influences myometrial contractility in mares with varying degrees of endometrosis, measuring expression of all six LPA receptors (LPAR1-6) and contractile responses across both luteal and follicular phases of the cycle. Key findings revealed that endometrosis alters myometrial receptor expression patterns and impairs the normal contractile response to LPA stimulation, with phase-specific differences suggesting cyclical hormonal influences on myometrial responsiveness. These results indicate that endometrosis compromises not only endometrial structure but fundamentally disrupts the neuromuscular signalling pathways governing uterine function, potentially explaining reduced embryo transport efficiency and subfertility in affected mares. For practitioners, this work highlights that myometrial dysfunction represents an underappreciated component of endometrosis pathology, suggesting future therapeutic strategies may need to target both endometrial inflammation and restoration of normal myometrial contractile responsiveness rather than addressing mucosal disease in isolation.

Read the full abstract on PubMed

Key Findings

• •Lysophosphatidic acid (LPA) influences myometrial contractility through its receptors (LPAR1-6) in mares with endometrosis
• •Myometrial LPAR1-6 mRNA transcription patterns differ between mares with and without endometrosis across estrous cycle phases
• •Endometrosis impairs the myometrial response to LPA-mediated signaling, particularly during specific cycle phases

Conditions Studied

Tags